Keros Therapeutics Inc (KROS)

Operating Income Growth

22.30%

Quarterly · Period ending:

KROS logo

KROS Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported22.30%
KROS Quarterly Operating Income YoY % (-267.53% → 22.30%)
High-resolution chart · PNG

KROS operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Operating Income Growth — Quarterly
Period endingOperating Income Growth
22.302%
-117.0199%
45.037%
73.773%
21.0591%
413.5945%
-14.6357%
-35.5291%
-22.019%
-24.7344%
-45.3536%
-54.704%
-34.5255%
-61.1083%
-556.8023%
-38.5156%
-97.7222%
-52.9964%
63.3888%
-69.0408%
-42.3951%
-50.1238%
-387.2067%
-413.6715%
-311.6937%
-267.5297%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.